CSIMarket
 
Aurora Cannabis Inc   (NASDAQ: ACB)
 

Aurora Cannabis Inc's Customers Performance

ACB



 
ACB's Source of Revenues During the corresponding time, Aurora Cannabis Inc While revenue at the Aurora Cannabis Inc 's corporate clients

List of ACB Customers




for the same period Aurora Cannabis Inc

List of ACB Customers

Aurora Cannabis Inc's Business Units
Canada    29.86 % of total Revenue
Australia    8.09 % of total Revenue
New Zealand    1.17 % of total Revenue
Europe    27.33 % of total Revenue






Aurora Cannabis Inc's Comment on Sales, Marketing and Customers



Aurora operates in the medical cannabis market primarily through its wholly owned subsidiary, CanvasRx Inc., and other cannabis clinics. The company provides patient counseling and outreach services to support the safe use of medical cannabis and assist in strain selection. Aurora distributes cannabis products mainly within the Canadian medical channel through online orders and a client care center, with delivery conducted via secured courier or other authorized methods. Following the wind-down of its consumer business in the fourth quarter of fiscal 2026, Aurora has limited activity in the Canadian consumer cannabis market. Internationally, the company distributes medical cannabis products in compliance with applicable laws, utilizing EU and TGA GMP certifications to access regulated markets in Europe and other regions. Aurora also engages in research and development aimed at improving cannabis genetics and reducing production costs.





Aurora Cannabis Inc’s Comment on Sales, Marketing and Customers


Aurora operates in the medical cannabis market primarily through its wholly owned subsidiary, CanvasRx Inc., and other cannabis clinics. The company provides patient counseling and outreach services to support the safe use of medical cannabis and assist in strain selection. Aurora distributes cannabis products mainly within the Canadian medical channel through online orders and a client care center, with delivery conducted via secured courier or other authorized methods. Following the wind-down of its consumer business in the fourth quarter of fiscal 2026, Aurora has limited activity in the Canadian consumer cannabis market. Internationally, the company distributes medical cannabis products in compliance with applicable laws, utilizing EU and TGA GMP certifications to access regulated markets in Europe and other regions. Aurora also engages in research and development aimed at improving cannabis genetics and reducing production costs.








ACB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aurora Cannabis Inc 0.00 369.53 -104.15 1,000
SUBTOTAL 0.00 0.00 0.00 -

Sources: Aurora Cannabis Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Aurora Cannabis Inc’s corporate clients.
For your research, we’ve provided 9 tables on Aurora Cannabis Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.